
|Articles|June 1, 2004
- Volume 0 0
dual path
Advertisement
Articles in this issue
over 21 years ago
Examover 21 years ago
Managed Care Commentary:MCOs face new challengesover 21 years ago
Phytosterols may play role in atherosclerosisover 21 years ago
Dual pathway inhibition: Attacking cholesterol on two frontsover 21 years ago
Future Goals, Targets, and Treatments of DyslipidemiaNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
2
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
3
Breaking News: CVS Buys Rite Aid, Bartell Drugs
4
Current and Emerging BCMAxCD3 Bispecifics
5